CHAMPIONS ONCOLOGY, INC. Income Statement
CSBR|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
CHAMPIONS ONCOLOGY, INC. reported $50M in revenue and $7M in net loss for FY2025. Revenue has grown at a 14.8% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.2M | $56.9M | $49.1M | $41.0M | $32.1M | $41.0M | $32.1M | $15.4M | $11.2M | $8.9M | $11.6M | $8.3M | $7.1M | $8.3M |
| Cost of Revenue | $29.4M | $28.4M | $23.6M | $21.4M | $17.0M | $21.4M | $17.0M | - | - | - | - | - | - | - |
| SG&A Expense | $11.1M | $9.3M | $9.1M | $6.5M | $6.6M | $6.5M | $6.6M | $5.0M | $5.2M | $5.3M | $6.1M | $4.6M | $5.5M | $4.6M |
| R&D Expense | $9.5M | $6.8M | $9.4M | $7.2M | $5.9M | $7.2M | $5.9M | $4.3M | $4.2M | $4.8M | $2.3M | $1.9M | $2.9M | $1.9M |
| Operating Income | -$7.4M | $4.6M | $607.0K | $366.0K | -$1.9M | $366.0K | -$1.9M | -$6.8M | -$10.3M | -$13.2M | -$6.3M | -$6.2M | -$9.1M | -$6.2M |
| Income Tax | -$32.0K | -$75.0K | $35.0K | $75.0K | $130.0K | $75.0K | $130.0K | $19.0K | $92.0K | $127.0K | $17.0K | $10.0K | -$2.0K | $10.0K |
| Net Income | -$7.3M | $4.7M | $548.0K | $362.0K | -$2.1M | $362.0K | -$2.1M | -$6.9M | -$10.4M | -$13.1M | -$7.4M | -$6.3M | -$8.7M | -$6.3M |
| EPS (Basic) | -$0.54 | -$0.39 | $0.04 | $0.03 | -$0.18 | $0.01 | -$0.13 | - | - | -$2.20 | -$0.11 | - | - | - |
| EPS (Diluted) | -$0.54 | -$0.39 | $0.04 | $0.02 | -$0.18 | $0.01 | -$0.13 | -$0.64 | -$1.20 | -$2.20 | -$0.11 | -$0.12 | -$0.19 | -$0.11 |
| Shares Outstanding | 13.6M | 13.5M | 13.5M | 13.4M | 12.7M | 11.6M | 11.0M | 11.0M | 8.7M | 8.7M | 66.9M | 35.6M | 34.5M | 33.9M |
| Operating Margin | -14.7% | 8.0% | 1.2% | 0.9% | -6.0% | 0.9% | -6.0% | -44.2% | -92.3% | -149.4% | -54.2% | -74.7% | -126.8% | -74.7% |
| Profit Margin | -14.5% | 8.3% | 1.1% | 0.9% | -6.5% | 0.9% | -6.5% | -44.7% | -93.4% | -148.3% | -64.1% | -76.0% | -121.2% | -76.0% |